Congenital angiosarcoma with transient response to paclitaxel

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 6, 2008, Pages 451-453

  Good, Amy B ^a,b   Nascimento, Antonio ^a   Welker, Kirk M ^a   Arndt, Carola A S ^a  

^a MAYO CLINIC   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Angiosarcoma; Congenital vascular tumor; Paclitaxel

Indexed keywords

CD31 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIPHENHYDRAMINE; ETOPOSIDE; FAMOTIDINE; ONDANSETRON; PACLITAXEL; PREDNISONE; TOPOTECAN; VINCRISTINE; ANTINEOPLASTIC AGENT;

AIRWAY OBSTRUCTION; ANGIOSARCOMA; ARTICLE; ATELECTASIS; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CYST RUPTURE; CYSTIC LYMPHANGIOMA; DRUG DOSE REDUCTION; ECTROPION; ENDOSCOPY; ENDOTHELIUM CELL; EPISTAXIS; EXTUBATION; FEMALE; FETUS ECHOGRAPHY; GESTATIONAL AGE; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INTRAOCULAR HEMORRHAGE; INTUBATION; KIDNEY METASTASIS; LIVER METASTASIS; LUNG METASTASIS; LYMPHADENOPATHY; NECK TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURA DISEASE; PLEURODESIS; PNEUMOTHORAX; PREMEDICATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SKIN DISCOLORATION; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR GROWTH; VAGINAL DELIVERY; DIFFERENTIAL DIAGNOSIS; FATALITY; HEAD AND NECK TUMOR; PATHOLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HEAD AND NECK NEOPLASMS; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LYMPHANGIOMA, CYSTIC; PACLITAXEL;

EID: 47549097561     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31816916d1     Document Type: Article

References (10)

1. Fata F, O'Reilly E, Ilson D, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999;86: 2034-2037.
2. Ferrari A, Casanova M, Bisogno G, et al. Malignant vascular tumors in children and adolescents: a report from the Italian and German soft tissue sarcoma cooperative group. Med Pediatr Oncol. 2002;39:109-114.
3. Lezama-del Valle P, Gerald W, Tsai J, et al. Malignant vascular tumors in young patients. Cancer. 1998;83:1634-1639.
4. Jennings LJ, Alagiozian-Angelova V. A 13-year-old adolescent girl with an abdominal mass 2 months after radiation for Hodgkin lymphoma. Arch Pathol Lab Med. 2005;129:e105-e106.
5. Dimashkieh HH, Mo JQ, Wyatt-Ashmead J, et al. Pediatric hepatic angiosarcoma: case report and review of the literature. Pediatr Dev Pathol. 2004;7:527-532.
6. Chapas A, Askarian F, Demierre M, et al. Well-differentiated angiosarcoma of the scalp: unusual clinical presentation to the editor. J Am Acad Dermatol. 2004;52:S58-S59.
7. McIntosh B, Narayan D. Head and neck angiosarcomas. J Craniofac Surg. 2005;16:699-703.
8. Del Mastro L, Garrone O, Guenzi M, et al. Angiosarcoma of the residual breast after conservative surgery and radiotherapy for primary carcinoma. Ann Oncol. 1994;5:163-165.
9. Cafiero F, Gipponi M, Peressini A, et al. Radiation-associated angiosarcoma diagnostic and therapeutic implications - two case reports and a review of the literature. Cancer. 1996;77:2496-2502.
10. Fury M, Antonescu C, Van Zee K, et al. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors and treatment outcomes with surgery and chemotherapy. Cancer J. 2005;11:241-247.